Chemotherapy of breast cancer.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000470:Alkaloids / Q000627:therapeutic use; D000477:Alkylating Agents / Q000627:therapeutic use; D000728:Androgens / Q000627:therapeutic use; D000963:Antimetabolites / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage; D001943:Breast Neoplasms / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000627:therapeutic use; D003596:Cytosine / Q000627:therapeutic use; D004967:Estrogens / Q000627:therapeutic use; D005472:Fluorouracil / Q000627:therapeutic use; D006728:Hormones / Q000627:therapeutic use; D006801:Humans; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D008937:Mitomycins / Q000627:therapeutic use; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use; D013852:Thiotepa / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000470:Alkaloids; D000477:Alkylating Agents; D000728:Androgens; D000963:Antimetabolites; D000970:Antineoplastic Agents; D004967:Estrogens; D006728:Hormones; D008937:Mitomycins; D009588:Nitrogen Mustard Compounds; D003596:Cytosine; D003520:Cyclophosphamide; D013852:Thiotepa; D015122:Mercaptopurine; D005472:Fluorouracil; D008727:Methotrexate